Alpha Teknova, Inc.
corporate_fare Company Profile
Alpha Teknova, Inc. (NASDAQ:TKNO) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 13 items for TKNO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 8/10, with 3 rated 8 or above. Recent SEC coverage for TKNO spans 8-K, 424B5, DEF 14A, 10-K.
Recent high-impact activity:
- Teknova Q3 Revenue Up 22% to $12.7M, Raises 2026 Revenue Guidance to $46-48M
- Teknova Q3 Revenue Tops Estimates at $12.7M, FY Outlook In Line
- Teknova's 8-K Confirms $40M Offering, 15% Share-Count Increase and Preliminary Q3 Beat
- Teknova Finalizes $40M Offering at $5.00, 12% Below Pre-Deal Price
- Teknova Prices $40M Offering at $5.00, a 12% Discount to Last Close
Financial Snapshot
Short Interest & Short Volume
1.40 days to coverFINRA reported short interest of 1,539,570 shares in TKNO as of the October 30, 2026 settlement, a 6.7% decrease from the prior period — about 1.4 days to cover at its recent average daily volume. On November 20, 2026, 52.6% of TKNO volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for TKNO, detected from its recent SEC filings · based on capital-structure filings through 2026-10-21.
8M Shares Priced at $5.00 · Net Proceeds and Fees
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →